0001140361-18-018859.txt : 20180417
0001140361-18-018859.hdr.sgml : 20180417
20180417201714
ACCESSION NUMBER: 0001140361-18-018859
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180416
FILED AS OF DATE: 20180417
DATE AS OF CHANGE: 20180417
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Symonds William T.
CENTRAL INDEX KEY: 0001635078
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34949
FILM NUMBER: 18760090
MAIL ADDRESS:
STREET 1: C/O ONCORE BIOPHARMA, INC.
STREET 2: 3805 OLD EASTON ROAD
CITY: DOYLESTOWN
STATE: PA
ZIP: 18902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arbutus Biopharma Corp
CENTRAL INDEX KEY: 0001447028
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980597776
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
BUSINESS PHONE: 604-419-3200
MAIL ADDRESS:
STREET 1: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp
DATE OF NAME CHANGE: 20110607
FORMER COMPANY:
FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20081003
4
1
doc1.xml
FORM 4
X0306
4
2018-04-16
0
0001447028
Arbutus Biopharma Corp
ABUS
0001635078
Symonds William T.
C/O ARBUTUS BIOPHARMA CORP.
SUITE 100, 8900 GLENLYON PARKWAY
BURNABY
A1
V5J 5J8
BRITISH COLUMBIA, CANADA
0
1
0
0
Chief Development Officer
Employee Stock Option (Right to Buy)
5.20
2018-04-16
4
A
0
30000
0
A
2028-04-16
Common Stock
30000
30000
D
The options vest as follows: 1/3 on April 16, 2019; 1/3 on April 16, 2020; and 1/3 on April 16, 2021.
/s/ William T. Symonds
2018-04-17